- Stimulus negotiations drag on
- FDA chief says agency will quickly approve Pfizer's (PFE.US) vaccine
- Walt Disney (DIS.US) stock rose 8% on strong subscriber growth
US indices launched today's session lower amid stimulus uncertainty and rising COVID-19 death toll. Dow Jones opened 0.3% lower, S&P 500 fell 0.4%, and the Nasdaq Composite dipped 0.5%. Democrats and Republicans could not agree on the issue of shielding companies from virus-related lawsuits, state and local stimulus, unemployment assistance and checks. Senate Majority Leader Mitch McConnell’s staff informed congressional leadership offices that Senate Republicans likely would not support a $908 billion bipartisan proposal, according to NBC News. Earlier on Thursday, House Speaker Nancy Pelosi said that bipartisan negotiations were leading to “great progress.” Also rising US death toll has tempered enthusiasm about the coming COVID-19 vaccine. Scientists expect the current pace to continue for the next two to three months, until the vaccine can be widely distributed. On the data front producer prices for final demand in the US edged up 0.1 % from a month earlier in November, following a 0.3 % increase in October and slightly missing market consensus of a 0.2 % gain.
US30- index broke below the major support at 30000 pts and is currently testing lower limit of the downward channel. If sellers will manage to close below it, then further downward impulse towards next support at 29557 pts could be launched. Source: xStation5Walt Disney (DIS.US) stock jumped 8% in premarket after company announced that number of subscribers of its Disney+ streaming service now surpassed 86.8 million. Company expects that this number could increase to 260 million by 2024. Since October, the service has added more than 13 million subscribers.
Walt Disney (DIS.US) stock launched today’s session with a massive bullish price gap and managed not only to break above the upper limit of the upward channel but also painted a fresh all-time high. However buyers failed to break above $171.00 level and price pulled back.Source: xStation5
Pfizer (PFE.US), BioNTech (BNTX.US) - a panel of experts formally recommended that the FDA authorize Pfizer and BioNTech’s coronavirus vaccine for emergency use putting it on course for approval by the FDA within days. The FDA issued a statement saying it would “rapidly work” toward a decision on the emergency use authorization. Also Pfizer will increase its quarterly dividend by 1 cent to 39 cents per share.
Vail Resorts (MTN.US) stock rose 1.8% in premarket after company reported a quarterly loss of $3.82 per share, while Wall Street expected smaller loss of $3.54 a share. Revenue also came in below forecasts. The resort operator results were impacted by capacity limitations and closures prompted by the Covid-19 pandemic.
Costco (COST.US) reported upbeat quarterly results. The warehouse retailer’s earned $2.29 per share, which came in 24 cents a share above market expectations. Revenue also exceeded estimates. Comparable sales rose 15.4% as the pandemic boosted by demand for groceries and other items.
Oracle (ORCL.US) reported quarterly earnings of $1.06 per share, while analysts expected earnings of $1.0 per share. The business software giant’s revenue came in line with expectations. The jump in remote work helped fuel demand for cloud-related offerings.
Airbnb (ABNB.US) shares dropped1.4%, consolidating after the house-sharing site’s stock more than doubled yesterday, after its highly publicized IPO.
